Deepika Jalota - Sep 11, 2024 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Development Officer
Signature
/s/ Robert Ticktin, by power of attorney
Stock symbol
PMVP
Transactions as of
Sep 11, 2024
Transactions value $
-$10,853
Form type
4
Date filed
9/12/2024, 06:00 PM
Previous filing
Oct 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Sale -$10.9K -7.22K -5.75% $1.50 118K Sep 11, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.